Reliance Life gains global rights for copies of InfliximabFor Infliximab, Reliance Life Sciences had completed process development, manufacturing, clinical trials in India and obtained marketing ap...
Reliance Life Sciences ends deal with Epirus for Remicade copiesJanssen’s Remicade is the third biggest pharmaceutical brand globally with sales exceeding $8 billion last year.
Ranbaxy launches arthritis drug Infimab in IndiaInfimab has been introduced in the Indian market through a licensing partnership with Epirus Biopharmaceuticals, Ranbaxy said in a statemen...